full-year results 2014 - de.marketscreener.com file3 . full-year results 2014 . targets achieved –...
TRANSCRIPT
18 February 2015
Full-Year Results 2014 18 FEBRUARY 2015
18 February 2015
Highlights
18 February 2015
CLARIANT CONTINUES TO DELIVER ON PROFITABLE GROWTH
Full-year 2014 – Strong growth and improved operating margins in an adverse environment
3 Full-Year Results 2014
Targets Achieved
– 5% sales growth in local currencies
– EBITDA margin above previous year in challenging environment
Further demonstrated operative strength
– Operating cash flow above previous year
– Net debt significantly reduced
– All Business Areas delivered strong underlying growth in adverse environment
18 February 2015
Key Figures Full-Year 2014
18 February 2015
5 Full-Year Results 2014
Full-year 2014 – solid results achieved
+5% sales growth in local currencies, +1% in CHF Sales
EBITDA* growth of 6% in LC; 1% in CHF Margin rises to 14.2% from 14.1% EBITDA*
CHF 235 million on higher taxes from CHF 323 million Net income before tax: +10% to CHF 379 million from CHF 345 million
Net income
FY 2014 vs. FY 2013, all figures continuing operations
* Before exceptional items
CHF 0.40/share from CHF 0.36/share from capital contribution reserves Dividend proposal
18 February 2015
Steady growth in all Business Areas in a challenging business environment
Full-Year Results 2014 6
Full-year 2014 Sales Change EBITDA* margin
Business Area CHF m % LC FY 2014 FY 2013
Care Chemicals** 1 511 +1 17.1 16.8
Catalysis & Energy 729 +7 23.5 22.3
Natural Resources 1 297 +8 14.7 15.2
Plastics & Coatings 2 579 +6 14.0 14.1
Total Group continuing*** 6 116 +5 14.2 14.1
* before exceptional items, in % of sales ** excluding impact from Care Chemicals portfolio measures: +3% in l.c. *** including corporate costs
18 February 2015
Fourth Quarter 2014 Results
18 February 2015
Growth driven by pricing, masked by deconsolidation
Full-Year Results 2014 8
Sales mix Q4 2014 Sales growth in local currencies
− Organic sales growth in LC driven by 2% higher prices
− Heterogeneous regional growth patterns. Strong double-digit growth in LATAM despite Brazil, good growth in Asia / Pacific with sales decline in China
− Europe further softened; Germany lower due to pruning of low margin products in Care Chemicals
Sales Q4 2014: CHF 1 586 m
Latin America 277 / +20%
Europe* 524 / −4%
North America 286 / +2% Asia / Pacific
389 / +4%
Middle East & Africa 110 / −9%
Germany* 192 / −5%
China 136 / −12%
Brazil 103 / 0%
all figures continuing operations
* excluding impact from Care Chemicals portfolio measures: Europe 0% / Germany +5%
Emerging Markets
Mature Markets
Volume 0%
Price 2%
Acq./Div. 0%
Currency -1%
18 February 2015
Gross margin improved compared to the prior-year period
− Sales prices +2% / raw material costs -1% year-on-year − Sales prices 0% / raw material costs -2% sequentially
EBITDA* and EBITDA* margin decreased slightly − EBITDA* decreased due to exceptional previous year high basis
in Natural Resources − Improved or stable EBITDA* margin in Care Chemicals,
Catalyst & Energy and Plastics & Coatings
Adj. EPS decreased to CHF 0.30/share from CHF 0.32/share in Q4 2013 − Net income from continuing operations improved to CHF 133 m from CHF 85 m − Higher net income mainly due to gain from land sale in India
Q4 EBITDA* rose, margin above previous year
Full-Year Results 2014 9
28.2%
28.8% Gross margin
15.0% 14.6%
EBITDA* margin
0.32
0.30 Adjusted EPS CHF/share
all figures continuing operations
Q4 2014 Q4 2013 * before exceptional items
235
232 EBITDA* CHF m
18 February 2015
Positive cash flow from operations
− Pronounced seasonal working capital reduction − NWC/sales ratio at 19.1% compared to 17.1% at the end of Q4 2013
Cash-out for restructuring decreased to CHF 24 million from CHF 35 million
− Cost incurred in smaller projects in the businesses and to streamline and optimize the service organization
Net debt at CHF 1 263 million compared to CHF 1 500 million at year-end 2013
− Net debt reduction through operating cash flow generation in the second half − Net debt level in-line with target of CHF 1.3 billion
Cash flow generation picked up in Q4. Net working capital clearly below 20%
Full-Year Results 2014 10
Operating cash flow
CHF m
-35
-24 Restructuring cash-out CHF m
1500
1263 Net debt CHF m
all figures continuing operations Q4 2014 Q4 2013
261
321
18 February 2015
Business Area Performance
18 February 2015
Good local currency sales growth in all Business Areas. Catalysis on same record level as Q4 2013
Full-Year Results 2014 12
Fourth Quarter 2014 Sales Change EBITDA* margin EBIT* margin
Business Area CHF m % CHF % LC Q4/14 Q4/13 Q4/14 Q4/13
Care Chemicals** 393 0 1 20.4 18.1 17.0 15.3
Catalysis & Energy 238 -3 0 24.8 24.9 18.9 18.0
Natural Resources 346 1 3 15.3 20.9 13.0 17.4
Plastics & Coatings 609 5 4 12.6 12.6 9.0 8.8
Continuing operations*** 1 586 1 2 14.6 15.0 10.0 10.0
* before exceptional items, in % of sales ** excluding impact from Care Chemicals portfolio measures: +6% in l.c. *** including corporate costs
18 February 2015
LC sales growth EBITDA* margin
Care Chemicals • Good underlying sales growth of 6% in local currencies, reported
sales were lower due to pruning of exposure to low-margin products
• Strong growth in Consumer Care, driven by double-digit growth in the Crop Solutions and high single-digit growth in Personal Care contributes to substantial improved EBITDA margin
• Successful launch of GlucoTain® an innovative new range of surfactants based on glucose and natural oils
+1% 20.4%
Catalysis & Energy • Sales growth of 7% in local currencies for FY 2014, Q4’14 tied the
record Q4 2013 despite the rebalancing of orders between the third and fourth quarters 2014
• EBITDA margin at same high level as last year
• Novel Heat Generating Material (HGM) concept increases the yield in on-purpose olefin production units by several percent
0% 24.8%
13 Full-Year Results 2014
Care Chemicals and Catalysis & Energy, good underlying growth and strong EBITDA margins
* Before exceptional items
18 February 2015
LC sales growth EBITDA* margin
Natural Resources • Underlying sales growth of 6% in local currencies, reported sales
were lower due to the divestment of Water Treatment
• Sales growth driven by strength in the Oil and Mining Services business as well as the Purification business
• Lower EBITDA margin compared to high base of Q4 2013
+3% 15.3%
Plastics & Coatings • Pigments good growth in LC sales in LATAM, NORAM and MEA
• Masterbatches sales grew due to Packaging and Auto. Europe slightly weaker during the quarter
• Additives good growth as demand for Flame Retardants continues to recover for electrical applications and electronics
+4% 12.6%
14 Full-Year Results 2014
Natural Resources good growth, profitability below tough base; Plastics & Coatings continued growth
* Before exceptional items
18 February 2015
Appreciation of Swiss franc basically a translation impact as transactional effects are fairly neutral
TRANSACTIONAL IMPACT OF CURRENCIES – Since 2011 Swiss franc cost base reduced by more
than 50% through to 4% of cost ~ CHF 250 million – Favorable effect of European manufacturing base – Remnant risk through volatile emerging market
currencies
NATURAL HEDGE FURTHER IMPROVED – 54% of investments in emerging markets and North
America to further improve the natural hedge, i.e: Polypropylene Catalyst facility in USA, Industrial Home Care expansion, USA. Bolt-on acquisitions in Asia etc.
Full-Year Results 2014 15
18 February 2015
Outlook – Focus On Performance, Growth & Innovation
18 February 2015 17 Full-Year Results 2014
Priorities 2015 – moving along the profitable growth path with focus on performance, growth, innovation
Growth Innovation
Performance
2015
2015 KEY ELEMENTS PERFORMANCE – Continued cost reduction and efficiency
– Clariant Excellence – Implementing new ways of doing business
GROWTH – Exploit growth markets in Asia
– Seize opportunities in developed and other emerging markets
INNOVATION – Strengthen organization and processes
– Develop innovation pipeline
– Promote communication and cooperation
Target: Growth, higher EBITDA margin and improved cash flow
18 February 2015
KEY METRICS IMPROVED
− Cost discipline across the company
− Efficient delivery of business services
− Avoiding remnant costs from divestments
− Investments into innovation and capex projects
Performance – higher profitability expected from cost efficiency and growth investments
Full-Year Results 2014 18
1 Intensify Lean Management
Operational Excellence Innovation Excellence
3 Accelerate Business Transformation
Commercial Excellence
2 Explore Growth
2015: GLOBAL BUSINESS SERVICES − Shared Service Centers in Mumbai and Lodz.
Take better advantage of company’s global footprint and identify more cost-efficient solutions
18 February 2015
Growth – selective adjustments of portfolio and investing into future growth markets
Full-Year Results 2014 19
54% of investments in emerging markets and North America (36% in 2013) Emerging markets earn 47% of group sales (37% in 2005)
EXAMPLE INDIA
− After acquisition of Plastichemix Industries Clariant now #1 Masterbatches producer in India
− Expansion of Pigment production in India (Roha, Cuddalore)
− New regional headquarters in Mumbai opened in June including regional innovation center for over 100 employees
EXAMPLE NORTH AMERICA − Clariant’s historic underrepresentation creates
profitable growth opportunities across virtually all BU’s
− ~50% of 2015 NORAM sales will be from businesses owned less than 5 years
− Cutting-edge Polypropylene Catalyst production in Louisville (KY, USA)
− Expansion in Industrial Home Care in Clear Lake (USA)
18 February 2015
Innovation – active management of innovation portfolio drives growth and profitability
Full-Year Results 2014 20
TARGET: 1-2% CONTRIBUTION FROM INNOVATION TO SALES GROWTH
− Sales at maturity: CHF 1.8 billion increase from CHF 540 million in 2012
− 300 active projects, thereof 63 prioritized as Class 1 projects (as of June 2014)
− 30 Class 1 projects will be launched until December 2015
NEW PRODUCT HIGHLIGHTS FROM CLARIANT − Glucamides: sugar-based surfactants, multi-
markets applications: Personal Care (Glucotain®); Industrial & Homecare (GlucoPure®); Crop Solutions (Synergen® GA)
− Heat Generating Material (HGM) concept developed with technology partner CB&I increases the yield in on-purpose olefin production units by several percent and reduces the carbon emissions by several 10 000 tons per year
− Polypropylene Catalyst – a new market opportunity for Clariant to be launched in 2016
18 February 2015 21 Full-Year Results 2014
Creating additional value through Sustainability – business benefits and Clariant’s approach
SUSTAINABILITY AT CLARIANT
»Clariant commits itself to ethical and sustainable operation and Development in all business activities according to Responsible Care® and Clariant’s own Code of Conduct. Clariant strives for a business culture of continuous improvement as well as for sustainable competitiveness and top performance in consideration of Clariant’s ethical standards.«
− Essential to achieve company targets
− Support profitable growth
− Create added value for stakeholders
− Anticipate and mitigate risk
EXTERNAL RECOGNITION OF SUSTAINABILITY PERFORMANCE
GLOBAL VOLUNTARY INITIATIVES AND PROGRAMS
SUSTAINABILITY IN THE SUPPLY CHAIN
18 February 2015
Summary – Further progress in the transformation of Clariant
Full-Year Results 2014 22
− 2014 - Clariant continued to deliver on targets despite slow-down in Europe and negative currency effects
− Further successful repositioning of portfolio in 2014; strong underlying growth in all Business Areas
− 2015 continued disciplined performance and cost management
− Future growth driven by
− Emerging and Growth Markets
− Innovations
− Sustainability
− 2015 focus on generating increased cash flow
− Proposed dividend increase: CHF 0.40/share from CHF 0.36/share
18 February 2015
Macroeconomic view
− Clariant expects an ongoing challenging environment characterized by an increased volatility in commodity prices and currencies
− The combined effect of the appreciation of the Swiss franc with the weakening of the euro will impact Clariant’s sales and profitability in absolute terms but will be fairly neutral in terms of relative margins
− In the emerging markets the economic environment is expected to remain favorable but at a lower level and with increased volatility; moderate growth expected in the United States, however, growth in Europe is expected to remain weak
Outlook 2015 – heterogeneous macroeconomic environment
Full-Year Results 2014 23
18 February 2015
2015 – Clariant will further progress in local currency and profitability
− Clariant will focus on profitably growing the four Business Areas and on cost efficiency
– For full-year 2015, Clariant expects low to mid-single digit sales growth in local currencies, an EBITDA margin before exceptional items above full-year 2014 and an increased cash flow generation
… and beyond
− 2015 will mark a further progress towards our mid-term target of becoming a leading company for specialty chemicals, achieving a position in the top tier of the industry. This corresponds to an EBITDA margin before exceptional items range of 16% to 19% and a return on invested capital (ROIC) above peer group average
24 Full-Year Results 2014
Outlook 2015 – further progress in sales and profitability
18 February 2015
Back-up Slides
18 February 2015
Clariant’s products and services are grouped into four Business Areas
Full-Year Results 2014 26
Natural Resources BA Natural Resources, comprising BUs Oil & Mining Services and Functional Minerals, is characterized by high growth and low cyclicality as well as strong megatrend orientation. Main drivers are the rising demand for high-value added specialty chemicals used in the oil, mining, food and packaging industries, and increased consumption of oil, gas and base metals, driven by the fast-growing economies.
Plastics & Coatings BA Plastics & Coatings comprises the BUs Additives, Pigments and Masterbatches. The BA has a large exposure to Europe and, as such, is subject to lower growth and to economic cycles. Main drivers are the increasing use of plastics with tailor-made properties in applications such as mobile phones, cars, construction, as well as the rising consumption of plastics in line with increased wealth.
Care Chemicals Business Area (BA) Care Chemicals comprises the Industrial & Consumer Specialties (ICS) Business Unit, food additives as well as the future Industrial Biotechnology business. It demonstrates a clear focus on highly attractive, high margin, and low cyclicality segments. The BA follows a lifestyle-driven megatrend and strengthens Clariant’s image of being a supplier of green and sustainable products.
Catalysis & Energy Business Area Catalysis & Energy develops, manufactures, and sells a wide range of catalyst products for the chemical, fuel and automotive industries, as well as producing materials for electric vehicles and energy storage systems. The BA is the smallest within Clariant but is highly profitable with high growth rates and low cyclicality.
18 February 2015
Selective investments – projects coming on stream in the next 1-2 years
Focused investments on growth areas based on step-change innovations to avoid overcapacities
Discover Innovation - Capital Markets and Media Days 2014 27
PROJECT BUSINESS LOCATION INVESTMENT (M CHF)
ON STREAM
Polypropylene Catalyst production Catalysts Louisville (KY), USA > 100 2015
Glucamide production Consumer Care Gendorf, Germany 25-50 2015
Industrial Home Care expansion Ind. & Cons. Spec. Clear Lake, USA 25-50 2015
Licocene Performance Polymer Additives Höchst, Germany < 25 2016
Industrial Home Care expansion Ind. & Cons. Spec. Dayabay, China < 25 2016
High Performance Pigments Pigments Zhenjiang, China 25-50 2016
Additives project Additives Zhenjiang, China 25-50 2016
18 February 2015
Sales growth driven by volumes – headwinds from FX in the first nine months
Full-Year Results 2014 28
Sales mix FY 2014 Sales growth in local currencies
Latin America 984 / +18%
Europe* 2 232 / -2 %
North America 1 006 / +3% Asia / Pacific
1 433 / +9%
Middle East & Africa 461 / +7%
Germany* 809 / −5%
China 519 / +9%
Brazil 405 / +4%
all figures continuing operations
* excluding impact from Care Chemicals portfolio measures: Europe +0% / Germany +0%
Emerging Markets
Mature Markets
Sales FY 2014: CHF 6 116 m
Volume 4%
Price 1% Acq./Div.
0%
Currency -4%
18 February 2015 29 Full-Year Results 2014
Key financials – full year
Full-year results (continuing operations) 2014 2013
CHF m % of sales CHF m % of sales Sales 6 116 100% 6 076 100%
Local currency growth (LC) 5% - Organic growth rate* 5% - Acquisitions/Divestments 0%
Currencies -4%
Gross profit 1 772 29.0% 1 744 28.7%
EBITDA before exceptionals 867 14.2% 858 14.1% EBITDA 923 15.1% 797 13.1%
Operating income before exceptionals 585 9.6% 574 9.4% Operating income 525 8.6% 470 7.7%
Net result from continuing operations 235 3.8% 323 5.3%
Net income** 217 5
Operating cash flow 334 301
Sales from discontinued operations 98 1 457
Net result from discontinued operations -18 -318
* Organic growth: volume and price effects excluding the impact of changes in foreign currency exchange rates and acquisitions/divestments ** Total Group, including discontinued operations
18 February 2015 30 Full-Year Results 2014
Cash flow – full year
Full-year results 2014 2013
CHF m CHF m
Net income 217 5 Depreciation, amortization and impairment 398 405 Other 57 318 Payments for restructuring -89 -133 Operating cash flow before working capital changes 583 595 Changes in working capital and provisions -249 -294 Operating cash flow 334 301 Cash flow from investing activities 31 100
thereof: property, plant and equipment -310 -292 thereof: changes in current financial assets and near cash assets -28 126 thereof: acquisitions, disposals and other 369 266
Cash flow before financing 365 401
18 February 2015 31 Full-Year Results 2014
Financial result – full year
Full-year results 2014 2013
CHF m CHF m Interest income 11 11 Other financial income 3 3 Total financial income 14 14 Interest expenses -129 -154 thereof: interest on non-current provisions -6 -4
thereof: interest on post-employment benefit obligations -23 -31
Other financial expenses -8 -10 Total financial expenses -137 -164 Currency result, net -25 -6 Total financial costs -162 -170 thereof reported under discontinued operations 2 31
Total financial costs (continuing operations) -160 -139
18 February 2015 32 Full-Year Results 2014
Sales and EBITDA margins by Business Area – full year
Full year results Business Area
Sales EBITDA* EBITDA margin*
CHF m % LC % of Group FY/14 FY/13
Care Chemicals 1 511 1 26 17.1 16.8
Catalysis & Energy 729 7 17 23.5 22.3
Natural Resources 1 297 8 20 14.7 15.2
Plastics & Coatings 2 579 6 37 14.0 14.1
Total continuing 6 116 5 100 14.2 14.1
EBITDA Sales in % of Group
Care Chemicals
25%
Catalysis & Energy
12%
Natural Resources
21%
Plastics & Coatings
42%
Care Chemicals
26%
Catalysis & Energy
17% Natural
Resources 20%
Plastics & Coatings
37%
* before exceptional items
18 February 2015
Sales in CHF m
2014 Change (LC) 2013
729 713
33 Full-Year Results 2014
Business Area performance – full year
Sales in CHF m
2014 Change (LC) 2013
1 511
1 561
Sales in CHF m
2014 Change (LC) 2013
1 297
1 281
EBITDA bef. exc. in CHF m
2014 Change (LC) 2013
259 17.1%
263 16.8%
EBITDA bef. exc. in CHF m
2014 Change (LC) 2013
191 14.7%
195 15.2%
Care Chemicals
Natural Resources
EBITDA bef. exc. in CHF m
2014 Change (LC) 2013
171 23.5%
159 22.3%
Catalysis & Energy
+1% +13%
Sales in CHF m
2014 Change (LC) 2013
2 579
2 521
EBITDA bef. exc. in CHF m
2014 Change (LC) 2013
360 14.0%
356 14.1%
Plastics & Coatings
+3%
+6% +5% +8%
+7%
+5%
18 February 2015 34 Full-Year Results 2014
Key financials – fourth quarter
Fourth quarter results 2014 2013
CHF m % of sales CHF m % of sales Sales 1 586 100% 1 563 100%
Local currency growth (LC) 2% - Organic growth rate* 2% - Acquisitions/Divestments 0%
Currencies -1%
Gross profit 456 28.8% 441 28.2%
EBITDA before exceptionals 232 14.6% 235 15.0% EBITDA 336 21.2% 207 13.2%
Operating income before exceptionals 159 10.0% 157 10.0% Operating income 234 14.8% 93 6.0%
Net result from continuing operations 133 8.4% 85 5.4%
Net income1 132 80
Operating cash flow 321 261
Sales from discontinued operations 0 142
Net result from discontinued operations -1 -5
* Organic growth: volume and price effects excluding the impact of changes in foreign currency exchange rates and acquisitions/divestments 1 Total Group, including discontinued operations
18 February 2015 35 Full-Year Results 2014
Cash flow – fourth quarter
Fourth quarter results 2014 2013
CHF m CHF m
Net income 132 80 Depreciation, amortization and impairment 102 114 Other -110 -25 Payments for restructuring -24 -35 Operating cash flow before working capital changes 100 134 Changes in working capital and provisions 221 127 Operating cash flow 321 261 Cash flow from investing activities 14 -83
thereof: property, plant and equipment -135 -85 thereof: changes in current financial assets and near cash assets 11 -70 thereof: acquisitions, disposals and other 138 72
Cash flow before financing 335 178
18 February 2015 36 Full-Year Results 2014
Financial result – fourth quarter
Fourth quarter results 2014 2013
CHF m CHF m Interest income 2 3 Other financial income 1 1 Total financial income 3 4 Interest expenses -31 -33 thereof: interest on non-current provisions -3 -1
thereof: interest on post-employment benefit obligations -5 -5
Other financial expenses -3 -3 Total financial expenses -34 -36 Currency result, net -9 -9 Total financial costs -43 -45 thereof reported under discontinued operations 0 6 Total financial costs (continuing operations) -43 -39
18 February 2015 37 Full-Year Results 2014
Sales and EBITDA margins by Business Area – fourth quarter
Fourth quarter results Business Area
Sales EBITDA* EBITDA margin*
CHF m % LC % of Group Q4/14 Q4/13
Care Chemicals 393 1 30 20.4 18.1
Catalysis & Energy 238 0 22 24.8 24.9
Natural Resources 346 3 20 15.3 20.9
Plastics & Coatings 609 4 28 12.6 12.6
Total continuing 1 586 2 100 14.6 15.0
EBITDA Sales in % of Group
Care Chemicals
25%
Catalysis & Energy
15%
Natural Resources
22%
Plastics & Coatings
38%
Care Chemicals
30%
Catalysis & Energy
22%
Natural Resources
20%
Plastics & Coatings
28%
* before exceptional items
18 February 2015
Sales in CHF m
2014 Change (LC)
Q4 2013
238 245
38 Full-Year Results 2014
Business Area performance – fourth quarter
Sales in CHF m
2014 Change (LC)
Q4 2013
393
393
Sales in CHF m
2014 Change (LC)
Q4 2013
346
344
EBITDA bef. exc. in CHF m
2014 Change (LC)
Q4 2013
80 20.4%
71 18.1%
EBITDA bef. exc. in CHF m
2014 Change (LC)
Q4 2013
53 15.3%
72 20.9%
Care Chemicals
Natural Resources
EBITDA bef. exc. in CHF m
2014 Change (LC)
Q4 2013
59 24.8%
61 24.9%
Catalysis & Energy
+1% 0%
Sales in CHF m
2014 Change (LC)
Q4 2013
609
581
EBITDA bef. exc. in CHF m
2014 Change (LC)
Q4 2013
77 12.6%
73 12.6%
Plastics & Coatings
+15%
+4% +6% +3%
0%
-26%
18 February 2015
Debt maturity profile as of 31 December 2014
Full-Year Results 2014 39
Liquidity
928
200 99 249 284 174 160
599
148
16 16
12
212
1 5
1
1 12
2
0
100
200
300
400
500
600
700
800
900
Cash* 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Derivatives
Uncommitted & other loans / NWC facilities
Long term loans
Certificate of Indebtedness
EUR Bond
CHF Bond
Cash*
Maturities of Financial Debt in CHF million
* Including near cash assets and financial instruments with positive fair values
18 February 2015 40 Full-Year Results 2014
Sales and cost structure*
EUR 41%
USD 38%
CHF 0% JPY
3%
Emerging markets 18%
EUR 46%
USD 32%
CHF 4%
JPY 3%
Emerging markets 15%
Global cost distribution in % Global sales distribution in %
*These distributions represent an approximation to total cash in- and out-flows and are closely linked to transaction exposures for FY 2014; Including discontinued operations.
18 February 2015
70%
11%
19%
41 Full-Year Results 2014
Top 20 chemicals in percentage of total raw material costs*
Top 5 Chemicals 1 Ethylene 2 Ethylene oxide 3 Propylenglycol 4 Polyethylene 5 Titanium dioxide
Approx. 45 chemicals account for 50% of material costs
Top 6-20
Top 5
Other
*As of 31 December 2014
Top 6-20 Chemicals 6 Propylene oxide 7 Phthalocyanine copper salt 8 Palladium 9 Tallow fatty acid
10 Acetic acid 11 Naphtha 12 Sodium hydroxide 13 Carbon Black
14 Dichlorobenzidine dihydrochloride
15 Bentonite 16 Alkyl benzene 17 Fatty alcohol 18 Ferric oxide 19 Polypropylene 20 Alkyldimethyl amines
18 February 2015
Calendar of upcoming corporate events
31 March 2015 Annual General Meeting, Basel
29 April 2015 First Quarter 2015 Results Conference Call
30 July 2015 Half Year 2015 Results Conference Call
29 October 2015 Nine Months 2015 Results Conference Call
42 Full-Year Results 2014
18 February 2015
IR contacts
43
Dr. Siegfried Schwirzer Deputy Head Investor Relations Phone +41 61 469 67 49 Mobile +41 79 718 45 98 E-mail [email protected]
Marco Ferraro Investor Relations Officer Phone +41 61 469 64 11 Mobile +41 79 931 03 98 E-mail [email protected]
Edith Schwab Phone +41 61 469 67 48 E-mail [email protected]
Mirjam Grieder Phone +41 61 469 67 66 E-mail [email protected]
Full-Year Results 2014
18 February 2015
iPad App: www.clariant.com/IRapp
Our Publications
Full-Year Results 2014 44
Factbook: www.clariant.com/factbook
18 February 2015
This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward-looking statements.
Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company's ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis.
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.
45 Full-Year Results 2014
Disclaimer